At the news
? NEUTRALIMPACT 2/10 144 filed Nov 2, 2026 at 14:55 ET
Director Howard J. Siegel filed a Form 144 notice of intent to sell 2,000 shares of CME Group common stock, with an approximate market value of $606,004. The shares were acquired through stock awards in 2022 and 2025. The sale is small relative to CME's $106B market cap and represents a routine diversification move by a director.
- Howard J. Siegel, a director of CME Group, filed Form 144 to sell 2,000 shares.
- The approximate value of the proposed sale is $606,004.
- Shares were acquired via stock awards on June 27, 2022 (1,121 shares) and June 25, 2025 (879 shares).
- The sale is to be executed through Fidelity Brokerage Services LLC.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access